Literature DB >> 9048911

Physical mapping and genomic structure of the Lowe syndrome gene OCRL1.

R L Nussbaum1, B M Orrison, P A Jänne, L Charnas, A C Chinault.   

Abstract

The oculocerebrorenal syndrome of Lowe (OCRL; McKusick 309,000) is a rare X-linked disorder characterized by mental retardation, congenital cataracts, and Fanconi syndrome of the proximal renal tubules. We have carried out physical mapping of the OCRL1 gene and determined that it contains 24 exons occupying 58 kb. The gene, located in Xq25-26, is transcribed in a centromeric to telomeric direction. Primers have been developed that allow all coding exons and their intron/exon boundaries to be amplified from genomic DNA for mutation detection. Two tetranucleotide tandem repeat polymorphisms were characterized that immediately flank the OCRL1 gene and, together, are informative in over 90% of females. Variable splicing was seen in the OCRL1 transcript, involving a small 24-bp exon. These results should prove useful to medical and molecular geneticists studying mutations and providing DNA diagnostic services to families dealing with Lowe syndrome as well as to cell biologists interested in structure-function relationships for the OCRL1 protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048911     DOI: 10.1007/s004390050329

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Antenatal diagnosis of Lowe syndrome.

Authors:  Sidharth Kumar Sethi; Joel Lunardi; Madhulika Kabra; Deepika Deka; Arvind Bagga
Journal:  Clin Exp Nephrol       Date:  2010-02-17       Impact factor: 2.801

2.  Novel OCRL1 gene mutations in six Chinese families with Lowe syndrome.

Authors:  Yan Gao; Fang Jiang; Zhi-Ying Ou
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

3.  Maternal de novo triple mosaicism for two single OCRL nucleotide substitutions (c.1736A>T, c.1736A>G) in a Lowe syndrome family.

Authors:  Markus Draaken; Carmen A Giesen; Anne L Kesselheim; Ronald Jabs; Stefan Aretz; Monika Kugaudo; Krystyna H Chrzanowska; Malgorzata Krajewska-Walasek; Michael Ludwig
Journal:  Hum Genet       Date:  2011-01-12       Impact factor: 4.132

4.  Clinical utility gene card for: Lowe syndrome.

Authors:  Arend Bökenkamp; Elena Levtchenko; Florian Recker; Michael Ludwig
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

5.  Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.

Authors:  P A Jänne; S F Suchy; D Bernard; M MacDonald; J Crawley; A Grinberg; A Wynshaw-Boris; H Westphal; R L Nussbaum
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.

Authors:  T Lin; B M Orrison; A M Leahey; S F Suchy; D J Bernard; R A Lewis; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene.

Authors:  V Satre; N Monnier; F Berthoin; C Ayuso; A Joannard; P S Jouk; I Lopez-Pajares; A Megabarne; H J Philippe; H Plauchu; M L Torres; J Lunardi
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

8.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

9.  The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module.

Authors:  Vanessa A van Rahden; Kristina Brand; Juliane Najm; Joerg Heeren; Suzanne R Pfeffer; Thomas Braulke; Kerstin Kutsche
Journal:  Hum Mol Genet       Date:  2012-08-19       Impact factor: 6.150

10.  [Clinical and genetic results with reference to corneal alterations in Lowe-syndrome].

Authors:  G Rudolph; P Kalpadakis; W Röschinger; C Haritoglou; S Kammerer; K-P Boergen; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.